Tesla
TSLA
MicroStrategy
MSTR
MARA Holdings
MARA
Apple
AAPL
Microsoft
MSFT
US Stock MarketDetailed Quotes
URGN UroGen Pharma Ltd
- 11.350
- -0.120-1.05%
Close Dec 13 16:00 ET
- 11.350
- 0.0000.00%
Post 16:20 ET
478.96MMarket Cap-3.76P/E (TTM)
11.500High11.100Low318.33KVolume11.430Open11.470Pre Close3.60MTurnover0.98%Turnover RatioLossP/E (Static)42.20MShares20.70052wk High18.76P/B367.15MFloat Cap10.60052wk Low--Dividend TTM32.35MShs Float69.568Historical High--Div YieldTTM3.49%Amplitude4.850Historical Low11.303Avg Price1Lot Size
UroGen Pharma Ltd Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 20.87%25.2M | 3.35%21.85M | 9.24%18.78M | 28.52%82.71M | 30.06%23.53M | 29.54%20.85M | 27.31%21.14M | 26.75%17.19M | 33.96%64.36M | 11.86%18.09M |
| Operating revenue | 20.87%25.2M | 3.35%21.85M | 9.24%18.78M | 28.52%82.71M | 30.06%23.53M | 29.54%20.85M | 27.31%21.14M | 26.75%17.19M | 33.96%64.36M | 11.86%18.09M |
| Cost of revenue | 3.63%2.45M | -8.76%2.23M | -23.71%1.73M | 22.30%9.36M | 1.02%2.29M | 17.18%2.37M | 32.34%2.44M | 48.52%2.27M | 48.42%7.65M | 42.42%2.26M |
| Gross profit | 23.08%22.75M | 4.94%19.62M | 14.24%17.05M | 29.36%73.35M | 34.21%21.24M | 31.31%18.49M | 26.68%18.7M | 23.99%14.93M | 32.22%56.7M | 8.53%15.83M |
| Operating expense | 25.98%40.3M | 33.39%45.46M | 15.74%42.79M | 2.32%138.89M | -0.71%35.85M | -0.56%31.99M | 1.81%34.08M | 8.75%36.97M | 0.42%135.74M | 4.67%36.11M |
| Selling and administrative expenses | 33.03%28.94M | 33.62%30.06M | 11.54%27.3M | 12.60%93.27M | 13.48%24.55M | 14.07%21.76M | 7.97%22.49M | 14.90%24.47M | -5.37%82.84M | 1.01%21.63M |
| Research and development costs | 11.00%11.36M | 32.96%15.4M | 23.97%15.49M | -13.78%45.61M | -21.93%11.3M | -21.87%10.23M | -8.35%11.58M | -1.56%12.5M | 11.05%52.91M | 10.66%14.48M |
| Operating profit | -29.96%-17.55M | -67.98%-25.84M | -16.76%-25.74M | 17.09%-65.54M | 27.97%-14.61M | 25.36%-13.5M | 17.81%-15.38M | -0.40%-22.05M | 14.36%-79.04M | -1.84%-20.28M |
| Net non-operating interest income expense | 101.21%36K | 47.71%-1.74M | 77.68%-649K | -60.99%-12.07M | -3.85%-2.86M | -32.27%-2.98M | -57.56%-3.33M | -938.57%-2.91M | -3,637.74%-7.5M | -1,970.68%-2.75M |
| Non-operating interest income | 230.18%2.76M | 295.86%1.72M | 178.76%1.8M | 181.56%2.64M | 54.80%726K | 89.34%835K | 239.84%435K | 32,150.00%645K | 156.99%938K | 2,245.00%469K |
| Non-operating interest expense | -28.68%2.72M | -7.98%3.46M | -31.13%2.45M | 74.39%14.72M | 11.26%3.59M | 41.61%3.82M | 67.98%3.76M | 1,159.93%3.55M | --8.44M | --3.22M |
| Other net income (expense) | -12.30%-6.07M | -7.69%-5.79M | -11.53%-5.84M | 3.60%-20.71M | 8.77%-4.69M | -13.09%-5.41M | 7.87%-5.37M | 10.14%-5.24M | -24.27%-21.49M | 29.21%-5.14M |
| Gain on sale of security | -7.96%-5.92M | -8.03%-5.77M | -8.35%-5.66M | 0.03%-21.55M | -8.34%-5.51M | -13.70%-5.48M | 8.38%-5.34M | 10.33%-5.22M | -24.68%-21.56M | 30.80%-5.08M |
| Other non- operating income (expenses) | -322.54%-158K | 53.33%-14K | -1,120.00%-183K | 1,063.89%838K | 1,388.89%812K | 91.89%71K | ---30K | -275.00%-15K | --72K | ---63K |
| Income before tax | -7.74%-23.58M | -38.55%-33.37M | -6.76%-32.23M | 8.98%-98.32M | 21.36%-22.16M | 12.87%-21.89M | 9.67%-24.08M | -7.57%-30.19M | 1.23%-108.03M | -3.17%-28.18M |
| Income tax | 1,111.11%91K | -29.63%38K | 157.14%54K | 123.36%3.92M | 459.36%3.85M | -101.27%-9K | 68.75%54K | -93.54%21K | 21.12%1.76M | -39.40%689K |
| Net income | -8.20%-23.67M | -38.39%-33.4M | -6.86%-32.29M | 6.87%-102.24M | 9.88%-26.02M | 15.30%-21.88M | 9.57%-24.14M | -6.41%-30.21M | 0.94%-109.78M | -1.47%-28.87M |
| Net income continuous Operations | -8.20%-23.67M | -38.39%-33.4M | -6.86%-32.29M | 6.87%-102.24M | 9.88%-26.02M | 15.30%-21.88M | 9.57%-24.14M | -6.41%-30.21M | 0.94%-109.78M | -1.47%-28.87M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -8.20%-23.67M | -38.39%-33.4M | -6.86%-32.29M | 6.87%-102.24M | 9.88%-26.02M | 15.30%-21.88M | 9.57%-24.14M | -6.41%-30.21M | 0.94%-109.78M | -1.47%-28.87M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -8.20%-23.67M | -38.39%-33.4M | -6.86%-32.29M | 6.87%-102.24M | 9.88%-26.02M | 15.30%-21.88M | 9.57%-24.14M | -6.41%-30.21M | 0.94%-109.78M | -1.47%-28.87M |
| Basic earnings per share | 19.12%-0.55 | 11.65%-0.91 | 25.38%-0.97 | 26.20%-3.55 | 45.90%-0.66 | 39.82%-0.68 | 12.71%-1.03 | -4.00%-1.3 | 3.02%-4.81 | 3.94%-1.22 |
| Diluted earnings per share | 19.12%-0.55 | 11.65%-0.91 | 25.38%-0.97 | 26.20%-3.55 | 45.90%-0.66 | 39.82%-0.68 | 12.71%-1.03 | -4.00%-1.3 | 3.02%-4.81 | 3.94%-1.22 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- |
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.